Clinical Trial Update: Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating escalating oral vitamin D replacement on insulin resistance (HOMA-IR) in vitamin D–deficient individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus
• Vitamin Deficiency

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: King Edward Medical University | Conditions: Vitamin D Deficiency, Insulin Resistance | Phase 4 | Status: COMPLETED